News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Biotech Fluorotechnics to Float Shares
September 4, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Biotech Fluorotechnics Ltd, which is seeking to raise up to $12 million through an initial public offer (IPO), discovered one of its main products by accident.
Twitter
LinkedIn
Facebook
Email
Print
Australia
MORE ON THIS TOPIC
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
March 7, 2025
·
2 min read
·
Tristan Manalac
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Drug Development
Kazia’s Star Asset Suffers Surprise Letdown in Global Glioblastoma Study
August 2, 2022
·
3 min read
·
Tristan Manalac
Drug Development
Sapience, Intensity, Kazia and Transcenta Tout Early Success at ASCO
June 3, 2022
·
3 min read
·
Vanessa Doctor, RN
